Bioceres Delays $130M IPO, Citing Market Volatility
Bioceres, represented by Linklaters LLP, had planned to raise about $130 million, assuming its 11.8 million American depositary shares priced at the middle of the projected range of $10 to $12. But the company on Thursday indefinitely delayed IPO plans, citing “volatile market conditions.”
“Subject to market conditions, the company expects to resume...
To view the full article, register now.